Skip to main content
JBM (Healthcare) Limited logo

JBM (Healthcare) Limited — Investor Relations & Filings

Ticker · 2161 HKEX Manufacturing
Open in API
Filings indexed 228 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2161

About JBM (Healthcare) Limited

http://www.jbmhealthcare.com.hk

JBM (Healthcare) Limited is a developer, manufacturer, marketer, and distributor of branded healthcare and wellness products across Asia. The company's portfolio includes over-the-counter (OTC) products and proprietary Chinese medicines (PCMs), focusing on clinically substantiated and consumer-preferred brands. JBM emphasizes a shift from treatment to prevention and early intervention, aiming to enhance personal health and wellbeing for individuals and families throughout the region.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings
2026-05-04 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 1% confidence The document is an announcement listing the company’s board of directors, their roles, and committee memberships effective from a specified date. This aligns with a Board/Management Information notice, which covers changes or details of the company’s board and senior management.
2026-04-30 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026
Regulatory Filings Classification · 1% confidence The document is a periodic monthly return (Form FF301) submitted to the Hong Kong Exchange detailing movements in authorised share capital, issued shares, treasury shares, share options, and public float confirmations pursuant to Listing Rules. It is not a full financial report (10-K/IR), not an AGM or earnings release, nor a board/management change, nor an M&A, dividend, or insider transaction notice. It represents a routine regulatory compliance filing with the Exchange rather than the issuance of new shares or a specific capital raise. Therefore, it falls under the general “Regulatory Filings” category.
2026-04-01 English
JOINT ANNOUNCEMENT RENEWAL OF CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings Classification · 1% confidence The document is a joint announcement by Jacobson Pharma Corporation Limited and JBM (Healthcare) Limited regarding the renewal of 'Continuing Connected Transactions' (Logistics and Manufacturing Services Agreements). It details the terms, pricing, historical transaction amounts, and annual caps for these agreements, and explains the Listing Rules implications. This type of disclosure is a standard regulatory requirement for listed companies in Hong Kong when entering into agreements with connected parties. Since it does not fit into specific categories like M&A (TAR) or Share Issues (SHA), and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2026-03-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2026
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. It does not fit into specific categories like 'Annual Report' or 'Earnings Release' but is a mandatory periodic regulatory filing. Given the specific nature of the HKEX monthly return, it falls under the 'Regulatory Filings' (RNS) category as a standard disclosure document.
2026-03-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2026
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. Since it is a recurring regulatory filing regarding share capital and securities movements that does not fit into specific categories like 'Share Issue' (which usually implies a specific event) or 'Transaction in Own Shares' (which is for specific buybacks), it falls under the 'Regulatory Filings' (RNS) category as the fallback for standard exchange-mandated disclosures.
2026-02-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.